Kane Biotech's revyve® Research Presented at Military Health System Research Symposium

Kane Biotech presented research on its revyve antimicrobial wound care gel spray at the Military Health System Research Symposium, highlighting its use for complex wounds in military and prolonged field care environments. The technology has FDA clearance and Health Canada approval and is attracting interest for further clinical evaluation in military and government healthcare settings.

This Wire brief sits within Fusion42's coverage of Medtech.